AGR in the News

M&A Opportunities in South East Asia

By Avalon Global ResearchDecember 10, 2016September 10th, 2020No Comments

The pharmaceuticals industry in Southeast Asia exhibits great potential with projected pharmaceutical sales of over US$40 billion by 2020.

Previous PostAvalon Global Research Releases Knowledge Paper in Association with FICCI at the FICCI Digital Travel, Hospitality & Innovation Summit
Next PostEmerging Opportunities for Food Processing Sector in the GCC Region